Formation Bio launches $600M AI-native drug development accelerator fund
anshulkundaje · x · 2026-10-29
AI-native pharma company Formation Bio announced a $600M Drug Development Accelerator Fund, described as the latest step toward building an enduring AI-native pharmaceutical company, with capital aimed at accelerating drug development programs.
Related event: Formation Bio Raises $600M Fund to Accelerate AI-Driven Drug Development(2 posts)→
More from Venture
- 34 Hypotheses: AI Agents Will Break Price Comparison Sites and Rework the Digital Economy — gaganghotra_ · 2026-10-29
- AI is creating volatility everywhere except in the volatility statistics — generativist · 2026-10-29
- Investor asks: what share of Google queries come from ad-proof AI agents? — firstadopter · 2026-10-29
- How Granola grew AI-search new users 4,600% in 7 months with an AEO workflow — jia_seed · 2026-10-29
- Autocomplete.dev brings Tab-style next-message suggestions to chatbots, 20k users already — josh_bickett · 2026-10-29
- Coinbase Agent trading hits all-time highs, with Grok Bot taking 67% of volume — MurrLincoln · 2026-10-29